From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

Risk Factors for Severe Consequences of Long-QT Syndrome in Adolescents

Beta-blocker therapy lowers risk.

The hereditary long-QT syndrome, with its prolonged ventricular repolarization, can lead to torsades de pointes, ventricular fibrillation, and sudden cardiac death. To identify factors associated with aborted cardiac arrest (requiring external defibrillation) and sudden cardiac death in adolescents with the syndrome, these authors analyzed data from the International Long QT Syndrome Registry for 2772 patients who were followed from age 10 to age 20 at five cardiac centers in the U.S. and Europe. The study was partly funded by a pharmaceutical company.

Overall, 81 patients had aborted cardiac arrests, and 54 experienced sudden cardiac death; 9 of the patients with aborted cardiac arrest subsequently experienced sudden cardiac death. The authors identified three independent risk factors for aborted cardiac arrest and sudden cardiac death (together termed life-threatening events): syncope, prolonged QTc, and male sex. The adjusted hazard ratios for the risk factors are as follows (see Table 1):


View this table:
[in a new window]
 
Table 1: Risk for Life-Threatening Events

 

There was no significant difference in risk for life-threatening events between males and females aged 13 to 20.

Comment: This study is the largest to date on long-QT syndrome and the first to report risk factors for life-threatening events. Of note, ß-blocker therapy in patients who had syncope during the previous 2 years reduced the risk for aborted cardiac arrest or sudden cardiac death by 64%.

— John A. Marx, MD, FAAEM, FACEP

Published in Journal Watch Emergency Medicine October 27, 2006

Citation(s):

Hobbs JB et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006 Sep 13; 296:1249-54.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.